Chronic myeloid leukemia

disorder

SNOMED 92818009CUI C0153887

Overview

By MedlinePlus, National Library of Medicine

NIH: National Cancer Institute Courtesy of the National Library of Medicine. Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Uramustine

substance

Idarubicin hydrochloride

substance

Idarubicin

substance

Interferon alfa-2b

substance

Plicamycin

substance

Busulphan

substance

Hydroxyurea

substance

Thioguanine

substance

Cyclophosphamide

substance

Bosutinib

substance

Bosutinib monohydrate

substance

Cyclophosphamide monohydrate

substance

Cyclophosphamide anhydrous

substance

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Myeloproliferative disorder

Always present (100%)HP:0005547

Abnormal basophil morphology

Frequent (30-79%)HP:0001912

Abnormality of granulocytes

Frequent (30-79%)HP:0001911

Hematologic disease

Frequent (30-79%)HP:0001871

Increased platelet count

Frequent (30-79%)HP:0001894

Increased total leukocyte count

Frequent (30-79%)HP:0001974

Large spleen

Frequent (30-79%)HP:0001744

No appetite

Frequent (30-79%)HP:0004396

Pyrexia

Frequent (30-79%)HP:0001945

Thrombocytopenia

Frequent (30-79%)HP:0001873

Tiredness

Frequent (30-79%)HP:0012378

Chronic myeloid leukemia

HP:0005506

Philadelphia-positive acute lymphoblastic leukemia

HP:0004848

Reduced leukocyte alkaline phosphatase

HP:0004852

Related Conditions

Chronic myeloid leukemia in remission(child)

JCML - Juvenile chronic myeloid leukaemia(child)

Leukaemic infiltration of skin in chronic myeloid leukaemia(child)

Chronic phase chronic myeloid leukemia(child)

Accelerated phase chronic myeloid leukemia(child)

Blastic phase chronic myeloid leukemia(child)

Relapsing chronic myeloid leukemia(child)

Chronic leukemia(parent)

Chronic myeloproliferative disorder (clinical)(parent)

Myeloid leukemia(parent)

Quick Facts

SNOMED CT: 92818009
UMLS CUI: C0153887
Fully Specified Name: Chronic myeloid leukemia (disorder)
Specialists: 0
Diagnostic Biomarkers: 0
HPO Phenotypes: 14
Known Treatments: 13

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.